Avista Capital Partners has announced it will sell Arcadia Consumer Healthcare to Bansk Group.
Arcadia, based in Bridgewater, N.J., is a provider of over-the-counter medicines, vitamins and nutritional supplements. Among its flagship brands: Nizoral, NATURELO, Kaopectate, Fungi-Nail and Opti-Nail. The company was formerly known as Kramer Laboratories.
Avista Capital Partners, based in New York, makes control buyout investments in middle market healthcare companies. Founded in 2005, the firm focuses on the following healthcare subsectors: pharmaceuticals, medical devices, outsourced pharmaceutical services, distribution and consumer-driven healthcare.
Bansk Group, based in New York, is a private equity firm focused on consumer buyouts and growth investing. Founded in 2019, the firm pursues investments in four primary consumer categories: household products, beauty and personal care, consumer health, and food and beverage.
Terms of the transaction were not disclosed.